Prudential Financial’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,700
Closed -$252K 2685
2024
Q1
$252K Buy
6,700
+2,972
+80% +$123K ﹤0.01% 2399
2023
Q4
$113K Hold
3,728
﹤0.01% 2493
2023
Q3
$81.7K Hold
3,728
﹤0.01% 2460
2023
Q2
$145K Buy
+3,728
New +$329K ﹤0.01% 2464

Other funds holding ACET

Prudential Financial's ACET Position: Q2 2024 in Review

Prudential Financial sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 6,700 shares — an estimated $252K sold.

Prudential Financial first reported a position in ACET in Q2 2023 and held it in 4 quarters. The position peaked at $252K in Q1 2024. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Prudential Financial reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Prudential Financial sold 6,700 Adicet Bio shares in Q2 2024, an estimated $252K.
  • Prudential Financial first reported a position in Adicet Bio in Q2 2023 and held it in 4 quarters.
  • Prudential Financial's Adicet Bio position peaked at $252K in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Prudential Financial's 13F filing for Q2 2024, filed 13 Aug 2024.